Randall B Brenner - Chief Development & Regulatory, Paratek Pharmaceuticals, Inc

As of December 15, 2021


Randall B Brenner Net Worth

  • Net worth is estimated to be at least $1.14M
  • Owns at least 253,530 units of Paratek Pharmaceuticals, Inc stock
  • Sold an estimated value of $512.12K in the last 2 years at Paratek Pharmaceuticals, Inc

Randall B Brenner Trading

  • Largest sale of shares was 27,894 units , worth over $120.54K on December 15, 2021
  • In total has made about 11 transactions over 2 years
  • Usually trades in December, with the busiest year in 2020 and 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Randall B Brenner Mailing Address

  • Mailing address is C/o Paratek Pharmaceuticals, Inc. 75 Park Plaza, 4th Floor Boston MA 02116 MA

Paratek Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Evan Loh, M.D. 2020 $575,000 - $505,440 $431,250 $22,921 $1,534,611
Evan Loh, M.D. 2019 $520,000 - $1,352,100 $364,375 $22,521 $2,258,996
Evan Loh, M.D. 2018 $480,000 - $1,011,725 $288,000 $21,434 $1,801,159
Michael F. Bigham 2020 $500,000 - $473,850 $375,000 $24,703 $1,373,553
Michael F. Bigham 2019 $515,000 - $1,352,100 $343,750 $22,928 $2,233,778
Michael F. Bigham 2018 $500,000 - $1,089,550 $330,000 $22,890 $1,942,440
Adam Woodrow 2020 $445,000 - $236,925 $250,313 $16,552 $948,790
Adam Woodrow 2019 $415,000 $48,375 $676,050 $193,500 $15,330 $1,348,225
Adam Woodrow 2018 $365,000 $35,040 $505,862 $140,160 $15,369 $1,061,431
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1178711/000120677421001229/prtk3887701-def14a.htm

Paratek Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 31,500 units sold on December 15, 2021 by Michael Bigham worth over $136.13K
  • In the last 6 years, insiders at Paratek Pharmaceuticals, Inc sold an estimated value of $8.11M and bought an estimated value of $12.81M
  • The most active traders are Evan Loh, CEO,  Michael Bigham, Exec. Chairman the Board,  and William M Haskel, CLO
  • Insider trading is most common in February, with the busiest year in 2018

Paratek Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1